Literature DB >> 18203262

Growth hormone action in the developing neural retina: a proteomic analysis.

Marie-Laure Baudet1, Zahra Hassanali, Grzegorz Sawicki, Edward O List, John J Kopchick, Steve Harvey.   

Abstract

The possible presence and action of growth hormone (GH) in the neural retina was investigated in newborn mice. The neural retina was found to be a site of GH gene expression, as GH mRNA was abundant in cells of the retinal ganglion cell layer, in which GH was also detected. It was also a site of GH action, since GH receptor (GHR) immunoreactivity mirrored that of GH. Actions of GH within the eye were indicated by a reduction in its axial length and retinal width (its neuroblastic, inner plexiform, and optic fiber layers) in GHR gene disrupted mice (GHR-/-), in comparison with wild type (GHR+/+) littermates. In the absence of GH signaling, four proteins in the retinal proteome of the GHR-/- mice (identified by 2-D gels and MS) differed in abundance with those in the wild type mice. Brain abundant membrane attached signal protein-1 (BASP-1) was down-regulated, whereas protein kinase C inhibitor 1, cyclophilin A, KH domain-containing, RNA-binding, signal transduction-associated protein 3 were up-regulated in GHR-/- mice. These proteins are involved in retinal vascularization, neural proliferation and neurite outgrowth. GH might thus have hitherto unsuspected roles in these processes during retinal development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18203262     DOI: 10.1002/pmic.200700952

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  12 in total

Review 1.  Proteomic studies on the development of the central nervous system and beyond.

Authors:  Chenggang Zhang
Journal:  Neurochem Res       Date:  2010-06-25       Impact factor: 3.996

Review 2.  Extrapituitary growth hormone.

Authors:  S Harvey
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

3.  Choroidal thickness measurements in children with isolated growth hormone deficiency.

Authors:  N G Yalcin; Z Aktas; O Yuce; G D G Ikiz; M Hasanreisoglu; A Bideci
Journal:  Eye (Lond)       Date:  2017-09-15       Impact factor: 3.775

4.  Selective inner retinal dysfunction in growth hormone transgenic mice.

Authors:  Brent T Martin; Edward O List; John J Kopchick; Yves Sauvé; Steve Harvey
Journal:  Growth Horm IGF Res       Date:  2011-06-25       Impact factor: 2.372

5.  Age- and sex-associated plasma proteomic changes in growth hormone receptor gene-disrupted mice.

Authors:  Juan Ding; Darlene E Berryman; Adam Jara; John J Kopchick
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-07       Impact factor: 6.053

6.  Cornea in acromegalic patients as a possible target of growth hormone action.

Authors:  A Ciresi; M C Amato; D Morreale; G Lodato; A Galluzzo; C Giordano
Journal:  J Endocrinol Invest       Date:  2010-07-22       Impact factor: 4.256

7.  Ocular findings in Sheehan's syndrome.

Authors:  Murat Atmaca; Esra Kızıldağ; Zehra Candan; Mehmet Fatih Özbay; İsmet Seven
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-01-10       Impact factor: 3.117

8.  MAP dendrimer elicits antibodies for detecting rat and mouse GH-binding proteins.

Authors:  Roberto M Aguilar; Frank J Talamantes; Juan J Bustamante; Jesus Muñoz; Lisa R Treviño; Andrew O Martinez; Luis S Haro
Journal:  J Pept Sci       Date:  2009-02       Impact factor: 1.905

9.  Comparing acromegalic patients to healthy controls with respect to intraocular pressure, central corneal thickness, and optic disc topography findings.

Authors:  Emine Sen; Yasemin Tutuncu; Ufuk Elgin; Melike Balikoglu-Yilmaz; Dilek Berker; F Nur Aksakal; Faruk Ozturk; Serdar Guler
Journal:  Indian J Ophthalmol       Date:  2014-08       Impact factor: 1.848

10.  Protein expression profiling during chick retinal maturation: a proteomics-based approach.

Authors:  Sorcha Finnegan; Joanne L Robson; Mildred Wylie; Adrienne Healy; Alan W Stitt; William J Curry
Journal:  Proteome Sci       Date:  2008-12-10       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.